Pfizer Inc.[PFE] stock saw a move by -0.42% on Friday, touching 24.0 million. Based on the recent volume, Pfizer Inc. stock traders appear to be active. The most recent trading volume of PFE shares recorded 5.55B shares, which represents the daily volume of traded shares. Analysts estimates state that Pfizer Inc. [PFE] stock could reach median target price of $41.50.
Pfizer Inc. [PFE] stock additionally went up by 1.45% in the period of the 7 days, recording a gain in performance by 5.24% in the last 30 days. The yearly more of PFE stock is set at -9.32% by far, with shares price recording returns by 3.42% in the latest quarter. Over the past six months, PFE shares showcased 3.17% increase. PFE saw 44.56 change opposing the low price in the last 12 months, also recording 27.88 compared to high within the same period of time.
Pfizer Inc. [NYSE:PFE]: Analyst Rating and Earnings
Equities traders oftentimes stay updated on what leading stock market analysts say about a potential stock purchase. On average, stock market experts give PFE an Overweight rating. The average 12-month price forecast for this stock is $37.76, with the high estimate being $53.00, the low estimate being $36.00 and the median estimate amounting to $41.50. This is compared to its latest closing price of $37.92.
Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Pfizer Inc. [PFE] is sitting at 3.88. This is compared to 1 month ago, when its average rating was 4.00.
Keep looking out for the next-scheduled quarterly financial results that this company is expected to put out, which is slated to occur on 08/04/2020.
Fundamental Analysis of Pfizer Inc. [PFE]
Now let’s turn to look at profitability: with a current Operating Margin for Pfizer Inc. [PFE] sitting at 32.20% and its Gross Margin at 80.40%, this company’s Net Margin is now 32.10. These measurements indicate that Pfizer Inc. [PFE] is generating considerably more profit, after expenses are accounted for, compared to its market peers.
This company’s Return on Total Capital is 12.69, and its Return on Invested Capital has reached 16.56. Its Return on Equity is 25.80%, and its Return on Assets is 9.90%. These metrics all suggest that Pfizer Inc. is doing well at using the money it earns to generate returns.
Turning to investigate this organization’s capital structure, Pfizer Inc. [PFE] has generated a Total Debt to Total Equity ratio of 84.69. Similarly, its Total Debt to Total Capital is 45.85, while its Total Debt to Total Assets stands at 31.93. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 58.62, and its Long-Term Debt to Total Capital is 31.73.
What about valuation? This company’s Enterprise Value to EBITDA is 12.44 and its Total Debt to EBITDA Value is 2.59. The Enterprise Value to Sales for this firm is now 4.94, and its Total Debt to Enterprise Value stands at 0.20. Pfizer Inc. [PFE] has a Price to Book Ratio of 3.43, a Price to Cash Flow Ratio of 17.66 and P/E Ratio of 13.51. These metrics all suggest that Pfizer Inc. is more likely to generate a positive ROI.
Pfizer Inc. [PFE] has 5.55B shares outstanding, amounting to a total market cap of 210.64B. Its stock price has been found in the range of 27.88 to 44.56. At its current price, it has moved down by -15.26% from its 52-week high, and it has moved up 35.44% from its 52-week low.
This stock’s Beta value is currently 0.71, which indicates that it is 2.57% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 56.21. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Pfizer Inc. [PFE] a Reliable Buy?
Shares of Pfizer Inc. [PFE], overall, appear to be a solid investment option, with Wall Street analysts expecting its price to rise considerably in the next 12 months. This company generates high value from the labor resources and other capital it has available, and while it has heavy Long-Term Debt to Equity, the majority of the metrics point to this investment being highly attractive.